151 related articles for article (PubMed ID: 26822604)
21. Human Bancroftian filariasis: loss of patent microfilaraemia is not associated with production of antibodies to microfilarial sheath.
Satapathy AK; Sahoo PK; Babu Geddam JJ; Mohanty MC; Ravindran B
Parasite Immunol; 2001 Mar; 23(3):163-7. PubMed ID: 11240907
[TBL] [Abstract][Full Text] [Related]
22. Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling.
Moraga P; Cano J; Baggaley RF; Gyapong JO; Njenga SM; Nikolay B; Davies E; Rebollo MP; Pullan RL; Bockarie MJ; Hollingsworth TD; Gambhir M; Brooker SJ
Parasit Vectors; 2015 Oct; 8():560. PubMed ID: 26496983
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of hydrocele as a rapid diagnostic index for lymphatic filariasis.
Gyapong JO; Webber RH; Morris J; Bennett S
Trans R Soc Trop Med Hyg; 1998; 92(1):40-3. PubMed ID: 9692148
[TBL] [Abstract][Full Text] [Related]
24. Pattern of Wuchereria bancrofti microfilaraemia in young and adolescent school children in Bassein, India, an endemic area for lymphatic filariasis.
Rajasekariah GR; Parab PB; Chandrashekar R; Deshpande L; Subrahmanyam D
Ann Trop Med Parasitol; 1991 Dec; 85(6):663-5. PubMed ID: 1811444
[No Abstract] [Full Text] [Related]
25. Immuno-parasitological assessment of bancroftian filariasis in a highly endemic area along the River Sabaki, in Malindi district, Kenya.
Njenga SM; Wamae CN; Mwandawiro CS; Molyneux DH
Ann Trop Med Parasitol; 2007 Mar; 101(2):161-72. PubMed ID: 17316502
[TBL] [Abstract][Full Text] [Related]
26. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine.
Ramaiah KD; Vanamail P; Das PK
Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):250-5. PubMed ID: 16890256
[TBL] [Abstract][Full Text] [Related]
27. Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand.
Bhumiratana A; Koyadun S; Srisuphanunt M; Satitvipawee P; Limpairojn N; Gaewchaiyo G
Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):390-407. PubMed ID: 15916046
[TBL] [Abstract][Full Text] [Related]
28. Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis.
Stolk WA; VAN Oortmarssen GJ; Pani SP; DE Vlas SJ; Subramanian S; DAS PK; Habbema JD
Am J Trop Med Hyg; 2005 Nov; 73(5):881-7. PubMed ID: 16282298
[TBL] [Abstract][Full Text] [Related]
29. Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka.
Gunawardena GS; Ismail MM; Bradley MH; Karunaweera ND
Ann Trop Med Parasitol; 2007 Jun; 101(4):335-41. PubMed ID: 17524248
[TBL] [Abstract][Full Text] [Related]
30. A comparison of the Og4C3 antigen capture ELISA, the Knott test, an IgG4 assay and clinical signs, in the diagnosis of Bancroftian filariasis.
Turner P; Copeman B; Gerisi D; Speare R
Trop Med Parasitol; 1993 Mar; 44(1):45-8. PubMed ID: 8516633
[TBL] [Abstract][Full Text] [Related]
31. The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity.
Simonsen PE; Meyrowitsch DW; Mukoko DA; Pedersen EM; Malecela-Lazaro MN; Rwegoshora RT; Ouma JH; Masese N; Jaoko WG; Michael E
Am J Trop Med Hyg; 2004 Jan; 70(1):63-71. PubMed ID: 14971700
[TBL] [Abstract][Full Text] [Related]
32. The effect of eight half-yearly single-dose treatments with DEC on Wuchereria bancrofti circulating antigenaemia.
Simonsen PE; Magesa SM; Meyrowitsch DW; Malecela-Lazaro MN; Rwegoshora RT; Jaoko WG; Michael E
Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):541-7. PubMed ID: 15869771
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
Kroidl I; Saathof E; Maganga L; Clowes P; Maboko L; Hoerauf A; Makunde WH; Haule A; Mviombo P; Pitter B; Mgeni N; Mabuye J; Kowuor D; Mwingira U; Malecela MN; Löscher T; Hoelscher M
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004618. PubMed ID: 27070786
[TBL] [Abstract][Full Text] [Related]
34. Immunoepidemiology of lymphatic filariasis: the relationship between infection and disease.
Bundy DA; Grenfell BT; Rajagopalan PK
Immunol Today; 1991 Mar; 12(3):A71-5. PubMed ID: 2069681
[TBL] [Abstract][Full Text] [Related]
35. Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.
Kyelem D; Medlock J; Sanou S; Bonkoungou M; Boatin B; Molyneux DH
Trop Med Int Health; 2005 Oct; 10(10):1002-4. PubMed ID: 16185234
[TBL] [Abstract][Full Text] [Related]
36. Further evidence of the cross-reactivity of the Binax NOW® Filariasis ICT cards to non-Wuchereria bancrofti filariae: experimental studies with Loa loa and Onchocerca ochengi.
Wanji S; Amvongo-Adjia N; Njouendou AJ; Kengne-Ouafo JA; Ndongmo WP; Fombad FF; Koudou B; Enyong PA; Bockarie M
Parasit Vectors; 2016 May; 9():267. PubMed ID: 27151313
[TBL] [Abstract][Full Text] [Related]
37. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.
Rajendran R; Sunish IP; Mani TR; Munirathinam A; Abdullah SM; Augustin DJ; Satyanarayana K
Ann Trop Med Parasitol; 2002 Sep; 96(6):595-602. PubMed ID: 12396322
[TBL] [Abstract][Full Text] [Related]
38. Bancroftian filariasis: effect of repeated treatment with diethylcarbamazine and albendazole on microfilaraemia, antigenaemia and antifilarial antibodies.
Helmy H; Weil GJ; Ellethy AS; Ahmed ES; Setouhy ME; Ramzy RM
Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):656-62. PubMed ID: 16414095
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-β1 variant Leu10Pro is associated with both lack of microfilariae and differential microfilarial loads in the blood of persons infected with lymphatic filariasis.
Debrah AY; Batsa L; Albers A; Mand S; Toliat MR; Nürnberg P; Adjei O; Hoerauf A; Pfarr K
Hum Immunol; 2011 Nov; 72(11):1143-8. PubMed ID: 21843572
[TBL] [Abstract][Full Text] [Related]
40. Persistent 'hotspots' of lymphatic filariasis microfilaraemia despite 14 years of mass drug administration in Ghana.
Biritwum NK; Yikpotey P; Marfo BK; Odoom S; Mensah EO; Asiedu O; Alomatu B; Hervie ET; Yeboah A; Ade S; Hinderaker SG; Reid A; Takarinda KC; Koudou B; Koroma JB
Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):690-695. PubMed ID: 28938053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
